The cross-national epidemiology of specific phobia in the World Mental Health Surveys

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorWARDENAAR, K. J.
dc.contributor.authorLIM, C. C. W.
dc.contributor.authorAL-HAMZAWI, A. O.
dc.contributor.authorALONSO, J.
dc.contributor.authorANDRADE, L. H.
dc.contributor.authorBENJET, C.
dc.contributor.authorBUNTING, B.
dc.contributor.authorGIROLAMO, G. de
dc.contributor.authorDEMYTTENAERE, K.
dc.contributor.authorFLORESCU, S. E.
dc.contributor.authorGUREJE, O.
dc.contributor.authorHISATERU, T.
dc.contributor.authorHU, C.
dc.contributor.authorHUANG, Y.
dc.contributor.authorKARAM, E.
dc.contributor.authorKIEJNA, A.
dc.contributor.authorLEPINE, J. P.
dc.contributor.authorNAVARRO-MATEU, F.
dc.contributor.authorBROWNE, M. Oakley
dc.contributor.authorPIAZZA, M.
dc.contributor.authorPOSADA-VILLA, J.
dc.contributor.authorHAVE, M. L. ten
dc.contributor.authorTORRES, Y.
dc.contributor.authorXAVIER, M.
dc.contributor.authorZARKOV, Z.
dc.contributor.authorKESSLER, R. C.
dc.contributor.authorSCOTT, K. M.
dc.contributor.authorJONGE, P. de
dc.date.accessioned2017-08-17T19:23:04Z
dc.date.available2017-08-17T19:23:04Z
dc.date.issued2017
dc.description.abstractBackground. Although specific phobia is highly prevalent, associated with impairment, and an important risk factor for the development of other mental disorders, cross-national epidemiological data are scarce, especially from low- and middle-income countries. This paper presents epidemiological data from 22 low-, lower-middle-, upper-middle- and high-income countries. Method. Data came from 25 representative population-based surveys conducted in 22 countries (2001-2011) as part of the World Health Organization World Mental Health Surveys initiative (n = 124 902). The presence of specific phobia as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition was evaluated using the World Health Organization Composite International Diagnostic Interview. Results. The cross-national lifetime and 12-month prevalence rates of specific phobia were, respectively, 7.4% and 5.5%, being higher in females (9.8 and 7.7%) than in males (4.9% and 3.3%) and higher in high- and higher-middle-income countries than in low-/lower-middle-income countries. The median age of onset was young (8 years). Of the 12-month patients, 18.7% reported severe role impairment (13.3-21.9% across income groups) and 23.1% reported any treatment (9.6-30.1% across income groups). Lifetime co-morbidity was observed in 60.5% of those with lifetime specific phobia, with the onset of specific phobia preceding the other disorder in most cases (72.6%). Interestingly, rates of impairment, treatment use and co-morbidity increased with the number of fear subtypes. Conclusions. Specific phobia is common and associated with impairment in a considerable percentage of cases. Importantly, specific phobia often precedes the onset of other mental disorders, making it a possible early-life indicator of psychopathology vulnerability.
dc.description.indexMEDLINE
dc.description.sponsorshipNational Institute of Mental Health (NIMH) [R01 MH070884]
dc.description.sponsorshipJohn D. and Catherine T. MacArthur Foundation
dc.description.sponsorshipPfizer Foundation
dc.description.sponsorshipUS Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]
dc.description.sponsorshipFogarty International Center (FIRCA) [R03-TW006481]
dc.description.sponsorshipPan American Health Organization (PAHO)
dc.description.sponsorshipEli Lilly and Company
dc.description.sponsorshipOrtho-McNeil Pharmaceutical
dc.description.sponsorshipGlaxoSmithKline
dc.description.sponsorshipBristol-Myers Squibb
dc.description.sponsorshipState of Sao Paulo Research Foundation (FAPESP) Thematic Project [03/00204-3]
dc.description.sponsorshipMinistry of Health
dc.description.sponsorshipNational Center for Public Health Protection
dc.description.sponsorshipShenzhen Bureau of Health
dc.description.sponsorshipShenzhen Bureau of Science, Technology, and Information
dc.description.sponsorshipMinistry of Social Protection
dc.description.sponsorshipCenter for Excellence on Research in Mental Health (CES University)
dc.description.sponsorshipSecretary of Health of Medellin
dc.description.sponsorshipEuropean Commission [QLG5-1999-01042, SANCO 2004123, EAHC 20081308]
dc.description.sponsorshipPiedmont Region (Italy)
dc.description.sponsorshipFondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS 00/0028]
dc.description.sponsorshipMinisterio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]
dc.description.sponsorshipDepartament de Salut, Generalitat de Catalunya, Spain
dc.description.sponsorshipInstituto de Salud Carlos III [CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]
dc.description.sponsorshipIraqi IMHS team
dc.description.sponsorshipJapanese Fund through the United Nations Development Group Iraq Trust Fund (UNDG ITF)
dc.description.sponsorshipEuropean Fund through the United Nations Development Group Iraq Trust Fund (UNDG ITF)
dc.description.sponsorshipJapan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]
dc.description.sponsorshipLebanese Ministry of Public Health
dc.description.sponsorshipWHO (Lebanon)
dc.description.sponsorshipNational Institute of Health/Fogarty International Center [R03 TW006481-01]
dc.description.sponsorshipSheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipEli Lilly
dc.description.sponsorshipHikma Pharmaceuticals
dc.description.sponsorshipJanssen Cilag
dc.description.sponsorshipLundbeck
dc.description.sponsorshipNovartis
dc.description.sponsorshipServier
dc.description.sponsorshipNational Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]
dc.description.sponsorshipNational Council on Science and Technology [CONACyT-G30544-H]
dc.description.sponsorshipPAHO
dc.description.sponsorship(Mexican) National Council of Science and Technology [CB-2010-01-155221]
dc.description.sponsorshipNew Zealand Ministry of Health
dc.description.sponsorshipAlcohol Advisory Council
dc.description.sponsorshipHealth Research Council
dc.description.sponsorshipWHO (Geneva)
dc.description.sponsorshipWHO (Nigeria)
dc.description.sponsorshipFederal Ministry of Health, Abuja, Nigeria
dc.description.sponsorshipHealth & Social Care Research & Development Division of the Public Health Agency
dc.description.sponsorshipNational Institute of Health of the Ministry of Health of Peru
dc.description.sponsorshipNorwegian Financial Mechanism
dc.description.sponsorshipEuropean Economic Area Mechanism
dc.description.sponsorshipPolish Ministry of Health
dc.description.sponsorshipChampalimaud Foundation
dc.description.sponsorshipGulbenkian Foundation
dc.description.sponsorshipFoundation for Science and Technology (FCT)
dc.description.sponsorshipEli Lilly Romania SRL
dc.description.sponsorshipMinistry of Public Health
dc.description.sponsorshipUS NIMH [R01-MH059575, RO1-MH61905]
dc.description.sponsorshipNational Institute of Drug Abuse (NIDA)
dc.description.sponsorshipSouth African Department of Health
dc.description.sponsorshipUniversity of Michigan
dc.description.sponsorshipRegional Health Authorities of Murcia (Servicio Murciano de Salud and Consejeria de Sanidad y Politica Social)
dc.description.sponsorshipFundacion para la Formacion e Investigacion Sanitarias (FFIS) of Murcia
dc.description.sponsorshipNIMH [U01-MH60220]
dc.description.sponsorshipNIDA
dc.description.sponsorshipSubstance Abuse and Mental Health Services Administration (SAMHSA)
dc.description.sponsorshipRobert Wood Johnson Foundation (RWJF) [044708]
dc.description.sponsorshipJohn W. Alden Trust
dc.description.sponsorshipVICI [91812607]
dc.description.sponsorshipNetherlands Research Foundation (NWO-ZonMW)
dc.identifier.citationPSYCHOLOGICAL MEDICINE, v.47, n.10, p.1744-1760, 2017
dc.identifier.doi10.1017/S0033291717000174
dc.identifier.eissn1469-8978
dc.identifier.issn0033-2917
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/21580
dc.language.isoeng
dc.publisherCAMBRIDGE UNIV PRESS
dc.relation.ispartofPsychological Medicine
dc.rightsrestrictedAccess
dc.rights.holderCopyright CAMBRIDGE UNIV PRESS
dc.subjectCo-morbidity
dc.subjectcross-national studies
dc.subjectepidemiology
dc.subjectimpairment
dc.subjectspecific phobia
dc.subject.otherprimary anxiety disorders
dc.subject.otherr psychiatric-disorders
dc.subject.otheriv specific phobia
dc.subject.othercomorbidity-survey
dc.subject.othergeneral-population
dc.subject.otheryoung-adults
dc.subject.otherlifetime prevalence
dc.subject.otherconditions nesarc
dc.subject.othertreatment contact
dc.subject.otherunited-states
dc.subject.wosPsychology, Clinical
dc.subject.wosPsychiatry
dc.subject.wosPsychology
dc.titleThe cross-national epidemiology of specific phobia in the World Mental Health Surveys
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryBulgária
hcfmusp.affiliation.countryPortugal
hcfmusp.affiliation.countryColômbia
hcfmusp.affiliation.countryPeru
hcfmusp.affiliation.countryAustrália
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryPolônia
hcfmusp.affiliation.countryLíbano
hcfmusp.affiliation.countryChina
hcfmusp.affiliation.countryJapão
hcfmusp.affiliation.countryNigéria
hcfmusp.affiliation.countryRomênia
hcfmusp.affiliation.countryBélgica
hcfmusp.affiliation.countryIraque
hcfmusp.affiliation.countryNova Zelândia
hcfmusp.affiliation.countryHolanda
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryIrlanda
hcfmusp.affiliation.countryMéxico
hcfmusp.affiliation.countryisonl
hcfmusp.affiliation.countryisonz
hcfmusp.affiliation.countryisoiq
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisomx
hcfmusp.affiliation.countryisoie
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisobe
hcfmusp.affiliation.countryisoro
hcfmusp.affiliation.countryisong
hcfmusp.affiliation.countryisojp
hcfmusp.affiliation.countryisocn
hcfmusp.affiliation.countryisolb
hcfmusp.affiliation.countryisopl
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisoau
hcfmusp.affiliation.countryisope
hcfmusp.affiliation.countryisoco
hcfmusp.affiliation.countryisopt
hcfmusp.affiliation.countryisobg
hcfmusp.affiliation.countryisous
hcfmusp.author.externalWARDENAAR, K. J.:Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands
hcfmusp.author.externalLIM, C. C. W.:Univ Otago, Dunedin Sch Med, Dept Psychol Med, Dunedin, New Zealand
hcfmusp.author.externalAL-HAMZAWI, A. O.:Al Qadisiya Univ, Coll Med, Al Diwaniya City, Iraq
hcfmusp.author.externalALONSO, J.:Hosp Mar, Inst Recerca, Inst Hosp Mar Invest Med, Hlth Serv Res Unit, Barcelona, Spain
hcfmusp.author.externalBENJET, C.:Natl Inst Psychiat Ramon de la Fuente, Dept Epidemiol & Psychosocial Res, Mexico City, DF, Mexico
hcfmusp.author.externalBUNTING, B.:Ulster Univ, Psychol Res Inst, Coleraine, Londonderry, North Ireland
hcfmusp.author.externalGIROLAMO, G. de:IRCCS Ctr S Giovanni Dio Fatebenefratelli, Brescia, Italy
hcfmusp.author.externalDEMYTTENAERE, K.:Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Psychiat, Leuven, Belgium
hcfmusp.author.externalFLORESCU, S. E.:Natl Sch Publ Hlth Management & Profess Dev, Bucharest, Romania
hcfmusp.author.externalGUREJE, O.:Univ Ibadan, Univ Coll Hosp, Coll Med, Dept Psychiat, Ibadan, Nigeria
hcfmusp.author.externalHISATERU, T.:Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Tokyo, Japan
hcfmusp.author.externalHU, C.:Shenzhen Inst Mental Hlth, Shenzhen, Guangdong, Peoples R China; Shenzhen Kangning Hosp, Shenzhen, Guangdong, Peoples R China
hcfmusp.author.externalHUANG, Y.:Peking Univ, Inst Mental Hlth, Beijing, Peoples R China
hcfmusp.author.externalKARAM, E.:Balamand Univ, Inst Dev, Res, St George Hosp,Univ Med Ctr, Beirut, Lebanon
hcfmusp.author.externalKIEJNA, A.:Wroclaw Med Univ, Dept Psychiat, Wroclaw, Poland
hcfmusp.author.externalLEPINE, J. P.:Paris Diderot Univ, INSERM, UMR S 1144, Hop Lariboisiere Fernand Widal,AP HP, Paris, France; Paris Descartes Univ, Paris, France
hcfmusp.author.externalNAVARRO-MATEU, F.:Inst Murciano Invest Biosanitaria IMIB Arrixaca, CIBERESP Murcia, Subdirecc Gen Salud Mental & Asistencia Psiquiatr, Serv Murciano Salud, El Palmar, Murcia, Spain
hcfmusp.author.externalBROWNE, M. Oakley:Monash Univ, Dept Psychiat, Melbourne, Vic, Australia
hcfmusp.author.externalPIAZZA, M.:Natl Inst Hlth, Lima, Peru
hcfmusp.author.externalPOSADA-VILLA, J.:Univ Cayetano Hereidia, St Martin De Porres, Peru; El Bosque Univ, Bogota, Colombia
hcfmusp.author.externalHAVE, M. L. ten:Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands
hcfmusp.author.externalTORRES, Y.:CES Univ, Ctr Excellence Res Mental Hlth, Medellin, Colombia
hcfmusp.author.externalXAVIER, M.:Univ Nova Lisboa, Fac Ciencias Med, Nova Fac Ciencias Med, Lisbon, Portugal
hcfmusp.author.externalZARKOV, Z.:Natl Ctr Publ Hlth & Analyses, Directorate Mental Hlth, Sofia, Bulgaria
hcfmusp.author.externalKESSLER, R. C.:Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
hcfmusp.author.externalSCOTT, K. M.:Univ Otago, Dunedin Sch Med, Dept Psychol Med, Dunedin, New Zealand
hcfmusp.author.externalJONGE, P. de:Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands
hcfmusp.citation.scopus139
hcfmusp.contributor.author-fmusphcLAURA HELENA SILVEIRA GUERRA DE ANDRADE
hcfmusp.description.beginpage1744
hcfmusp.description.endpage1760
hcfmusp.description.issue10
hcfmusp.description.volume47
hcfmusp.origemWOS
hcfmusp.origem.pubmed28222820
hcfmusp.origem.scopus2-s2.0-85013374219
hcfmusp.origem.wosWOS:000404354500005
hcfmusp.publisher.cityNEW YORK
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAlonso J, 2004, ACTA PSYCHIAT SCAND, V109, P28
hcfmusp.relation.referenceAndrade LH, 2014, PSYCHOL MED, V44, P1303, DOI 10.1017/S0033291713001943
hcfmusp.relation.referenceAngermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x
hcfmusp.relation.referenceAngst J, 2016, EPIDEMIOL PSYCH SCI, V25, P24, DOI 10.1017/S204579601500027X
hcfmusp.relation.referenceBecker ES, 2007, EUR PSYCHIAT, V22, P69, DOI 10.1016/j.eurpsy.2006.09.006
hcfmusp.relation.referenceBijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098
hcfmusp.relation.referenceBijl RV, 2002, SOC PSYCH PSYCH EPID, V37, P372, DOI 10.1007/s00127-002-0566-3
hcfmusp.relation.referenceBittner A, 2004, J CLIN PSYCHIAT, V65, P618
hcfmusp.relation.referenceBurstein M, 2012, DEPRESS ANXIETY, V29, P1072, DOI 10.1002/da.22008
hcfmusp.relation.referenceChoy Y, 2007, CLIN PSYCHOL REV, V27, P266, DOI 10.1016/j.cpr.2006.10.002
hcfmusp.relation.referenceClement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129
hcfmusp.relation.referenceComer JS, 2011, J CLIN PSYCHIAT, V72, P43, DOI 10.4088/JCP.09m05094blu
hcfmusp.relation.referenceCurtis GC, 1998, BRIT J PSYCHIAT, V173, P212, DOI 10.1192/bjp.173.3.212
hcfmusp.relation.referencede Graaf R, 2012, SOC PSYCH PSYCH EPID, V47, P203, DOI 10.1007/s00127-010-0334-8
hcfmusp.relation.referenceDepla MFIA, 2008, SOC PSYCH PSYCH EPID, V43, P200, DOI 10.1007/s00127-007-0291-z
hcfmusp.relation.referenceFredrikson M, 1996, BEHAV RES THER, V34, P33, DOI 10.1016/0005-7967(95)00048-3
hcfmusp.relation.referenceGoisman R M, 1998, Depress Anxiety, V7, P105, DOI 10.1002/(SICI)1520-6394(1998)7:3<105::AID-DA2>3.0.CO;2-A
hcfmusp.relation.referenceGoodwin RD, 2002, PSYCHOL MED, V32, P1121, DOI 10.1017/S0033291702005482
hcfmusp.relation.referenceGrant BF, 2009, MOL PSYCHIATR, V14, P1051, DOI 10.1038/mp.2008.41
hcfmusp.relation.referenceGrenier S, 2011, DEPRESS ANXIETY, V28, P456, DOI 10.1002/da.20812
hcfmusp.relation.referenceHalli S. S., 1992, ADV TECHNIQUES POPUL
hcfmusp.relation.referenceHarkness J., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P91
hcfmusp.relation.referenceHaro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196
hcfmusp.relation.referenceHinton DE, 2009, CNS NEUROSCI THER, V15, P207, DOI 10.1111/j.1755-5949.2009.00097.x
hcfmusp.relation.referenceHofmann SG, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0450-3
hcfmusp.relation.referenceIza M, 2013, J CLIN PSYCHIAT, V74, P1093, DOI 10.4088/JCP.13m08361
hcfmusp.relation.referenceKessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313
hcfmusp.relation.referenceKessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
hcfmusp.relation.referenceKessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
hcfmusp.relation.referenceKessler RC, 1996, BRIT J PSYCHIAT, V168, P17
hcfmusp.relation.referenceKESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
hcfmusp.relation.referenceKessler RC, 2008, WHO WORLD MENTAL HLT
hcfmusp.relation.referenceLeBeau RT, 2010, DEPRESS ANXIETY, V27, P148, DOI 10.1002/da.20655
hcfmusp.relation.referenceLee S, 2009, J COMMUN HEALTH, V34, P144, DOI 10.1007/s10900-008-9137-1
hcfmusp.relation.referenceLeon AC, 1997, INT J PSYCHIAT MED, V27, P93
hcfmusp.relation.referenceLevinson D, 2010, BRIT J PSYCHIAT, V197, P114, DOI 10.1192/bjp.bp.109.073635
hcfmusp.relation.referenceLieb R, 2016, DEPRESS ANXIETY, V33, P667, DOI 10.1002/da.22487
hcfmusp.relation.referenceMagee WJ, 1996, ARCH GEN PSYCHIAT, V53, P159
hcfmusp.relation.referenceMarques L, 2011, EXPERT REV NEUROTHER, V11, P313, DOI [10.1586/ern.10.122, 10.1586/ERN.10.122]
hcfmusp.relation.referenceMcBain R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001166
hcfmusp.relation.referenceMoffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036
hcfmusp.relation.referenceOrmel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107
hcfmusp.relation.referencePalazzo MC, 2014, HUM PSYCHOPHARM CLIN, V29, P211, DOI 10.1002/hup.2397
hcfmusp.relation.referenceSaxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2
hcfmusp.relation.referenceSemrau M, 2015, EPIDEMIOL PSYCH SCI, V24, P382, DOI 10.1017/S2045796015000359
hcfmusp.relation.referenceSigstrom R, 2016, DEPRESS ANXIETY, V33, P339, DOI 10.1002/da.22459
hcfmusp.relation.referenceStinson FS, 2007, PSYCHOL MED, V37, P1047, DOI 10.1017/S0033291707000086
hcfmusp.relation.referenceten Have M, 2013, PSYCHIAT SERV, V64, P981, DOI 10.1176/appi.ps.201200454
hcfmusp.relation.referenceTrumpf J, 2010, SOC PSYCH PSYCH EPID, V45, P1161, DOI 10.1007/s00127-009-0159-5
hcfmusp.relation.referenceWells JE, 2006, AUST NZ J PSYCHIAT, V40, P845, DOI 10.1080/j.1440-1614.2006.01903.x
hcfmusp.relation.referenceWolter KM, 1985, INTRO VARIANCE ESTIM
hcfmusp.relation.referenceWorld Bank, 2008, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-7462-7
hcfmusp.relation.referenceZimmermann P, 2003, PSYCHOL MED, V33, P1211, DOI 10.1017/S0033291703008158
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublicationfb08711c-e402-4736-ae73-151116153731
relation.isAuthorOfPublication.latestForDiscoveryfb08711c-e402-4736-ae73-151116153731
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_WARDENAAR_The_crossnational_epidemiology_of_specific_phobia_in_the_2017.PDF
Tamanho:
240.66 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/23